FamiCord AG (LTS:0NLV) Margin of Safety % (DCF Dividends Based): N/A (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0NLV FamiCord AG LTS:0NLV
38 GF Score
Price €2.78
GF Value €17.48
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is FamiCord AG Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

FamiCord AG's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

LTS:0NLV vs HCA, THC, EHC: Margin of Safety % (DCF Dividends Based) Comparison

For the Medical Care Facilities subindustry, FamiCord AG's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FamiCord AG Margin of Safety % (DCF Dividends Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, FamiCord AG's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where FamiCord AG's Margin of Safety % (DCF Dividends Based) falls into.


LTS:0NLV
38GF Score
FamiCord AG LTS:0NLV
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is FamiCord AG (LTS:0NLV) Overvalued in 2026?

Based on GuruFocus' analysis, FamiCord AG stock appears to be undervalued. The current stock price of €2.78 is trading 84.1% below its estimated GF Value™ of €17.48. GuruFocus considers FamiCord AG to be Possible Value Trap.

Key valuation signals for LTS:0NLV:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: €17.48 vs. price of €2.78 (84.1% below fair value)
  • GF Score™: 38/100 with 3 warning signs

No single metric tells the full story. See the LTS:0NLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

FamiCord AG Business Description

Other Exchanges V3V:Germany
Address Perlickstrase 5, Leipzig, DEU, D-04103
FamiCord AG is a German-based cord blood and tissue bank operating through subsidiaries including Vita 34 and PBKM (Polish Stem Cell Bank). The company collects, processes, cryopreserves, and stores umbilical cord blood and cord tissue stem cells for private family banking and public donation programs. It also provides logistics for sample collection and laboratory services. Beyond storage, FamiCord is expanding into cell and gene therapies and contract development and manufacturing (CDMO) services, positioning itself as a broader cell bank capable of supplying patients' own cells for current and future therapies. Its customer base includes families storing stem cells privately, public banks, hospitals, and research or clinical partners. The company operates primarily in Germany, Poland, Switzerland, and other European markets, generating revenue mainly from storage fees, processing services, and increasingly from cell therapy and CDMO activities.
38GF Score

Get the complete analysis for LTS:0NLV

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.78
Price
€17.48
GF Value